Recent data also demonstrate that ICOS-expressing CD4 are restricted to the tumor stroma, where the majority of MHCII-expressing cells are located31, suggesting that this response does not rely on direct antigen presentation by cancer cells, despite the impact of radiation on MHC expression by cancer cells5. This evidence concerns the gene ICOS and neoplasm.